Search Results

BEPH Brookfield BRP Holdings (Canada - Fundamental Analysis

BEARISH
Sign in to save Save this symbol to a watchlist or track a position.
BEPH Stock | Fundamental Analysis & Investment Insights
NYSE N/A N/A
Current Price Live
$15.12
52W High
$16.89
52W Low
$13.96
Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Jan 24, 2026
Market cap
N/A
P/E
N/A
ROE
N/A
Profit margin
N/A
Debt/Equity
N/A
Dividend yield
N/A

AI Analysis

Powered by advanced machine learning algorithms

Confidence Score
65%
Analysis Accuracy
The company exhibits critically weak financial health with a Piotroski F-Score of just 1/9, indicating severe deterioration in fundamental performance. The absence of an Altman Z-Score and all key valuation, profitability, and financial health metrics prevents a comprehensive safety assessment, but the lack of data itself signals transparency or reporting risks. Despite modest 3-year price appreciation (+17.1%), the stock has underperformed over five years (-18.5%) and shows no discernible technical trend. With no dividend strength, weak insider sentiment (40/100), and no analyst coverage, the investment case lacks supporting evidence across all dimensions.

Key Strengths

Modest 3-year price appreciation (+17.1%) suggests some resilience or cyclical recovery
Current price ($15.12) is below 52-week high ($16.89), potentially indicating near-term downside containment
Insider sentiment, while neutral-weak, is not strongly negative (40/100)
No reported dividend payout, eliminating risk of unsustainable yield
Price stability over short term with only minor declines in past month and week

Key Risks

Critically low Piotroski F-Score (1/9) signals severe deterioration in earnings, leverage, liquidity, and operating efficiency
Absence of Altman Z-Score prevents bankruptcy risk assessment, but missing financials imply potential distress
No available valuation metrics (P/E, P/B, EV/EBITDA, etc.) limits ability to assess overvaluation or undervaluation
Complete lack of analyst coverage and target prices indicates low institutional interest or data opacity
Negative 5-year total return (-18.5%) reflects long-term underperformance despite recent short-term gains

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
20
Weak
Value
20
Future
25
Past
40
Health
10
Dividend
5
AI Verdict
High-risk, low-conviction investment with insufficient data and weak fundamentals
Key drivers: Piotroski F-Score of 1 severely penalizes health score, Missing financials prevent reliable valuation or growth assessment, No analyst coverage or intrinsic value estimate increases uncertainty, Mixed price performance with long-term underperformance, Neutral-insider sentiment provides minor offset
Confidence
60%
Value
20/100

Ref P/E, PEG, Graham Number

Positives
No standout positives identified.
Watchpoints
  • All valuation metrics (P/E, P/B, PEG, EV/EBITDA) are unavailable
  • Graham Number is undefined, preventing defensive value assessment
Future
25/100

Ref Growth rates

Positives
  • 3-year price change of +17.1% suggests potential for future stabilization
Watchpoints
  • No forward P/E, earnings growth, or revenue growth data available
  • No analyst target prices or growth estimates
Past
40/100

Ref Historical trends

Positives
  • 6M and 3Y returns are positive (+2.5%, +17.1%)
  • Current price near midpoint of 52-week range
Watchpoints
  • 5Y price change is -18.5%, indicating long-term underperformance
  • 1Y and 1M returns are nearly flat, suggesting stagnation
Health
10/100

Ref Altman Z-Score, Piotroski F-Score

Positives
No standout positives identified.
Watchpoints
  • Piotroski F-Score is 1/9 — among the weakest possible health readings
  • All financial health metrics (Debt/Equity, Current Ratio, ROE, ROIC) are missing
  • Altman Z-Score is unavailable, preventing distress risk evaluation
Dividend
5/100

Ref Yield, Payout

Positives
No standout positives identified.
Watchpoints
  • Dividend Strength is 0/100
  • All dividend metrics (yield, payout, ex-date) are unavailable

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$15.12

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for BEPH and closest competitors.

Updated 2026-01-23
Company 5Y 3Y 1Y 6M 1M 1W
BEPH
Brookfield BRP Holdings (Canada
Primary
 -18.5% +17.1% +1.0% +2.5% -0.1% -0.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
N/A
PEG Ratio
N/A
P/B Ratio
N/A
P/S Ratio
N/A
EV/Revenue
N/A
EV/EBITDA
N/A
Market Cap
N/A

Profitability

Profit margins and return metrics

Profit Margin N/A
Operating Margin N/A
Gross Margin N/A
ROE N/A
ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth N/A
Earnings Growth N/A
Q/Q Revenue Growth N/A
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
N/A
Current Ratio
N/A
Quick Ratio
N/A
Cash/Share
$N/A

Past News Coverage

Recent headlines mentioning BEPH from our newsroom.

Newest → oldest
Back to All Stocks
TradingGPT V1 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Features Intelligence Terminal AI Assistant Trading Challenge Analysis Market News Pricing
Sign In Get Started
Home
Terminal
AI
Markets
Profile